PROLUNG
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
The University of Hong Kong
Overview
PROLUNG is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
PROLUNG clinical trials
Explore related
Medical disclaimer. This page summarizes research about PROLUNG for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.